LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Aix-Marseille University
Marsella, FranciaPublicaciones en colaboración con investigadores/as de Aix-Marseille University (6)
2023
-
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Journal of Thoracic Oncology, Vol. 18, Núm. 12, pp. 1731-1742
2019
-
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2109-2119
2018
-
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non–Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care
Clinical Lung Cancer, Vol. 19, Núm. 6, pp. e823-e830
-
Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
Clinical Lung Cancer, Vol. 19, Núm. 4, pp. 301-314
2017
-
Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057)
Journal of Clinical Oncology, Vol. 35, Núm. 35, pp. 3924-3933
2014
-
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations
Clinical Cancer Research, Vol. 20, Núm. 16, pp. 4251-4261